title: [Biological response modifier activity of Lactococcus lactis 332].
abstract: The biological response modifier (BRM) activity of a preparation of heat killed cells of Lactococcus lactis 332 which can produce large amount of lactate in culture, was investigated in C3H/He and ICR mice. Intraperitoneal injection of Lactococcus lactis 332 caused an accumulation of neutrophils and macrophages in the peritoneal cavity of the mice, similarly to BRMs used clinically. As a parameter of the activation of macrophages, the effect of the Lactococcus lactis 332 preparation on the production of tumor necrosis factor (TNF) was examined. The Lactococcus lactis 332 preparation was revealed to have both priming and triggering activities for the production of TNF. The TNF level in the sera reached about 1000 IU/ml in mice 2 h after the triggering injection. This preparation also stimulated peritoneal macrophages to produce TNF in vitro. Intratumoral injection of the Lactococcus lactis 332 preparation regressed MM46 tumor cells in C3H/He mice. These results suggest that the Lactococcus lactis 332 preparation is a biological response modifier (BRM) with various activities on phagocytes similarly to a streptococcal antitumor agent, OK432, used clinically.
authors.affiliation: Faculty of Pharmaceutical Sciences, Teikyo University, Kanagawa, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Maeda
authors.forename: H
authors.initials: H
authors.lastname: Ueda
authors.forename: M
authors.initials: M
authors.lastname: Yamazaki
authors.forename: M
authors.initials: M
authors.lastname: Ohtsuka
authors.forename: U
authors.initials: U
authors.lastname: Doi
mesh_terms: D000818:Animals; D005260:Female; D007155:Immunologic Factors / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D015552:Injections, Intralesional; D013294:Lactococcus lactis / Q000737:chemistry / Q000502:physiology*; D008262:Macrophage Activation / Q000187:drug effects; D017737:Macrophages, Peritoneal / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology; D051379:Mice; D008809:Mice, Inbred C3H; D008813:Mice, Inbred ICR; D009504:Neutrophils / Q000276:immunology; D010537:Peritoneum / Q000166:cytology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha